MECP2 and atypical Rett syndrome: Importantly, although these phenotypes vary depending on the cell type, the age and type of Mecp2 mutations, soma size is consistently reduced throughout development of mouse models of Rett syndrome, therefore appearing as a robust and reliable biomarker (Wang et al,2013).